Wyoming Pharmacy
Board Jurisprudence
(MPJE): Comprehensive
Analytical Report and
Elite Test Bank
Table of Contents
● PART I: THE PREVIEW
○ 1.1 Jurisprudential Context & Axiomatic Frameworks
○ 1.2 Structural Data: Timelines, Expirations, and Authority
● PART II: THE ELITE TEST BANK
○ Tier 1 (Questions 1–18): Foundational Syntax & Application
○ Tier 2 (Questions 19–37): Complex Application & Simulation
○ Tier 3 (Questions 38–55): Grandmaster Synthesis
PART I: THE PREVIEW
1.1 Jurisprudential Context & Axiomatic Frameworks
Mastering the Wyoming Pharmacy Act and the Wyoming Controlled Substances Act requires
transcending baseline memorization to anticipate regulatory logic in high-stakes clinical
environments. Precision in interpreting these statutes ensures absolute licensure protection and
elite patient care standards. The regulatory environment in Wyoming uniquely balances rural
healthcare access—evidenced by progressive telepharmacy and collaborative practice
statutes—with stringent diversion controls, particularly regarding opioid administration and data
retention.
Recent legislative updates have fortified the state’s stance on controlled substance tracking and
prescribing limits. Effective January 1, 2021, all controlled substance prescriptions (Schedules
II-V) must be transmitted electronically, barring highly specific statutory exceptions such as
emergencies or technical failures. Furthermore, the state has implemented aggressive
measures to curb the opioid epidemic through strict limitations on initial prescribing.
● Critical Axioms:
○ The 7-45 Rule (Opioid Naivety): Opioid-naive patients—defined legally as
individuals lacking an active opioid prescription in the preceding 45 days—are
, strictly limited to a 7-day supply of opioids for acute pain.
○ The DEA 106 Mandate: Theft or significant loss of controlled substances demands
dual-track reporting: notification to the local DEA field office and the Wyoming
Board of Pharmacy within exactly one (1) business day, followed by the submission
of DEA Form 106 within 45 days.
○ The May Inventory Dictate: A complete physical inventory of all controlled
substances must be conducted annually during the first seven (7) days of May,
deviating from the federal biennial standard, unless an alternate date is explicitly
Board-approved.
○ The Temporal Data Boundary: Wyoming prescription records and dispensing logs
must be retained for two (2) years. Conversely, Prescription Drug Monitoring
Program (PMP) data is strictly retained for five (5) years before being de-identified
for epidemiological research.
○ The Emergency C-II Protocol: Oral Schedule II authorizations are permitted only
under strict emergency criteria. The quantity is limited strictly to the emergency
period, and the prescriber MUST provide a written or electronic follow-up
prescription to the pharmacy within seven (7) days, mirroring federal 21 CFR
§1306.11(d).
1.2 Structural Data: Timelines, Expirations, and Authority
To facilitate rapid clinical decision-making, the following tables synthesize the statutory
constraints governing Wyoming pharmacy practice.
Regulatory Domain Wyoming Statutory Reference Framework
Requirement
PMP Reporting Close of the next business day W.S. § 35-7-1060
(Zero-reports required)
C-II Expiration Six (6) months from the date of W.S. § 35-7-1030
issuance
C-III, IV, V Expiration Six (6) months from the date of W.S. § 35-7-1030
issuance (Max 5 refills)
Legend Drug Expiration Two (2) years from the date of W.S. § 33-24-101
issuance
PIC Change Notice Seven (7) days (Requires Wyo. Code R. 059-19-9
mandatory CS inventory)
Non-Resident Pharmacy Toll-free access 40 hours/week W.S. § 33-24-152
across 6 days/week
Telepharmacy Distance Ten (10) miles minimum from W.S. § 33-24-156
an existing retail pharmacy
License Type Annual CE Renewal Date Specific CE Mandates
Requirement
Pharmacist 12 Hours Dec 31 1.5 hrs Controlled
Substances; 1 hr
Immunizations (if
applicable)
Pharmacy Technician 10 Hours Dec 31 1 hr Immunizations (if
, License Type Annual CE Renewal Date Specific CE Mandates
Requirement
applicable)
Pharmacy Facility N/A June 30 Resident,
Non-Resident, and CS
Registrations
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: A patient presents an electronic prescription for oxycodone for acute pain. The patient has
not had an active opioid prescription in the past 45 days. Based on the principles of the
Wyoming Controlled Substances Act, which action is the MAXIMUM permitted supply? A)
Dispense a 3-day supply B) Dispense a 5-day supply C) Dispense a 7-day supply D) Dispense
a 14-day supply
● Answer: C (Dispense a 7-day supply)
● Distractor Analysis:
○ A is incorrect: A 3-day limit reflects proposed federal legislation or other state laws,
not Wyoming statute.
○ B is incorrect: A 5-day limit applies to specific pediatric populations in other
jurisdictions (e.g., Minnesota).
○ D is incorrect: The 14-day limit was a proposed Wyoming amendment that was
rejected in favor of the 7-day mandate.
The Mentor's Analysis: Wyoming strictly defines an opioid-naive patient as one lacking an active
opioid prescription for 45 days. To combat diversion, acute pain prescriptions for these
individuals hit a statutory hard deck at 7 days. When facing an acute pain opioid prescription,
the immediate priority is verifying the 45-day history. By utilizing the PMP, you bypass the
common trap of over-dispensing to naive patients. Professional Intuition: Always apply the
7-day maximum to opioid-naive patients unless a statutory exception (e.g., cancer,
palliative care) is explicitly documented.
Q2: A resident retail pharmacy experiences a sudden change in the Pharmacist-in-Charge
(PIC). Based on the principles of Wyoming Board of Pharmacy regulations, which timeline is the
STRICTEST requirement for notifying the Board? A) Within 24 hours of the change B) Within 7
days of the change C) Within 10 days of the change D) Within 14 days of the change
● Answer: B (Within 7 days of the change)
● Distractor Analysis:
○ A is incorrect: 24 hours is the requirement for reporting significant loss or theft, not
a personnel change.
○ C is incorrect: 10 days is the timeframe for reporting inventory discrepancies
discovered during quarterly reconciliation.
○ D is incorrect: 14 days represents administrative grace periods in other states.
The Mentor's Analysis: The PIC holds ultimate accountability for pharmacy operations. The
Board mandates rapid notification to ensure continuous oversight, which simultaneously triggers
a mandatory controlled substance inventory. When facing a PIC transition, the immediate
priority is submitting written notice. By utilizing the 7-day rule, you bypass the common trap of
regulatory lapse. Professional Intuition: A PIC change instantly initiates a 7-day Board
notification clock and mandates a day-one controlled substance inventory.
Board Jurisprudence
(MPJE): Comprehensive
Analytical Report and
Elite Test Bank
Table of Contents
● PART I: THE PREVIEW
○ 1.1 Jurisprudential Context & Axiomatic Frameworks
○ 1.2 Structural Data: Timelines, Expirations, and Authority
● PART II: THE ELITE TEST BANK
○ Tier 1 (Questions 1–18): Foundational Syntax & Application
○ Tier 2 (Questions 19–37): Complex Application & Simulation
○ Tier 3 (Questions 38–55): Grandmaster Synthesis
PART I: THE PREVIEW
1.1 Jurisprudential Context & Axiomatic Frameworks
Mastering the Wyoming Pharmacy Act and the Wyoming Controlled Substances Act requires
transcending baseline memorization to anticipate regulatory logic in high-stakes clinical
environments. Precision in interpreting these statutes ensures absolute licensure protection and
elite patient care standards. The regulatory environment in Wyoming uniquely balances rural
healthcare access—evidenced by progressive telepharmacy and collaborative practice
statutes—with stringent diversion controls, particularly regarding opioid administration and data
retention.
Recent legislative updates have fortified the state’s stance on controlled substance tracking and
prescribing limits. Effective January 1, 2021, all controlled substance prescriptions (Schedules
II-V) must be transmitted electronically, barring highly specific statutory exceptions such as
emergencies or technical failures. Furthermore, the state has implemented aggressive
measures to curb the opioid epidemic through strict limitations on initial prescribing.
● Critical Axioms:
○ The 7-45 Rule (Opioid Naivety): Opioid-naive patients—defined legally as
individuals lacking an active opioid prescription in the preceding 45 days—are
, strictly limited to a 7-day supply of opioids for acute pain.
○ The DEA 106 Mandate: Theft or significant loss of controlled substances demands
dual-track reporting: notification to the local DEA field office and the Wyoming
Board of Pharmacy within exactly one (1) business day, followed by the submission
of DEA Form 106 within 45 days.
○ The May Inventory Dictate: A complete physical inventory of all controlled
substances must be conducted annually during the first seven (7) days of May,
deviating from the federal biennial standard, unless an alternate date is explicitly
Board-approved.
○ The Temporal Data Boundary: Wyoming prescription records and dispensing logs
must be retained for two (2) years. Conversely, Prescription Drug Monitoring
Program (PMP) data is strictly retained for five (5) years before being de-identified
for epidemiological research.
○ The Emergency C-II Protocol: Oral Schedule II authorizations are permitted only
under strict emergency criteria. The quantity is limited strictly to the emergency
period, and the prescriber MUST provide a written or electronic follow-up
prescription to the pharmacy within seven (7) days, mirroring federal 21 CFR
§1306.11(d).
1.2 Structural Data: Timelines, Expirations, and Authority
To facilitate rapid clinical decision-making, the following tables synthesize the statutory
constraints governing Wyoming pharmacy practice.
Regulatory Domain Wyoming Statutory Reference Framework
Requirement
PMP Reporting Close of the next business day W.S. § 35-7-1060
(Zero-reports required)
C-II Expiration Six (6) months from the date of W.S. § 35-7-1030
issuance
C-III, IV, V Expiration Six (6) months from the date of W.S. § 35-7-1030
issuance (Max 5 refills)
Legend Drug Expiration Two (2) years from the date of W.S. § 33-24-101
issuance
PIC Change Notice Seven (7) days (Requires Wyo. Code R. 059-19-9
mandatory CS inventory)
Non-Resident Pharmacy Toll-free access 40 hours/week W.S. § 33-24-152
across 6 days/week
Telepharmacy Distance Ten (10) miles minimum from W.S. § 33-24-156
an existing retail pharmacy
License Type Annual CE Renewal Date Specific CE Mandates
Requirement
Pharmacist 12 Hours Dec 31 1.5 hrs Controlled
Substances; 1 hr
Immunizations (if
applicable)
Pharmacy Technician 10 Hours Dec 31 1 hr Immunizations (if
, License Type Annual CE Renewal Date Specific CE Mandates
Requirement
applicable)
Pharmacy Facility N/A June 30 Resident,
Non-Resident, and CS
Registrations
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: A patient presents an electronic prescription for oxycodone for acute pain. The patient has
not had an active opioid prescription in the past 45 days. Based on the principles of the
Wyoming Controlled Substances Act, which action is the MAXIMUM permitted supply? A)
Dispense a 3-day supply B) Dispense a 5-day supply C) Dispense a 7-day supply D) Dispense
a 14-day supply
● Answer: C (Dispense a 7-day supply)
● Distractor Analysis:
○ A is incorrect: A 3-day limit reflects proposed federal legislation or other state laws,
not Wyoming statute.
○ B is incorrect: A 5-day limit applies to specific pediatric populations in other
jurisdictions (e.g., Minnesota).
○ D is incorrect: The 14-day limit was a proposed Wyoming amendment that was
rejected in favor of the 7-day mandate.
The Mentor's Analysis: Wyoming strictly defines an opioid-naive patient as one lacking an active
opioid prescription for 45 days. To combat diversion, acute pain prescriptions for these
individuals hit a statutory hard deck at 7 days. When facing an acute pain opioid prescription,
the immediate priority is verifying the 45-day history. By utilizing the PMP, you bypass the
common trap of over-dispensing to naive patients. Professional Intuition: Always apply the
7-day maximum to opioid-naive patients unless a statutory exception (e.g., cancer,
palliative care) is explicitly documented.
Q2: A resident retail pharmacy experiences a sudden change in the Pharmacist-in-Charge
(PIC). Based on the principles of Wyoming Board of Pharmacy regulations, which timeline is the
STRICTEST requirement for notifying the Board? A) Within 24 hours of the change B) Within 7
days of the change C) Within 10 days of the change D) Within 14 days of the change
● Answer: B (Within 7 days of the change)
● Distractor Analysis:
○ A is incorrect: 24 hours is the requirement for reporting significant loss or theft, not
a personnel change.
○ C is incorrect: 10 days is the timeframe for reporting inventory discrepancies
discovered during quarterly reconciliation.
○ D is incorrect: 14 days represents administrative grace periods in other states.
The Mentor's Analysis: The PIC holds ultimate accountability for pharmacy operations. The
Board mandates rapid notification to ensure continuous oversight, which simultaneously triggers
a mandatory controlled substance inventory. When facing a PIC transition, the immediate
priority is submitting written notice. By utilizing the 7-day rule, you bypass the common trap of
regulatory lapse. Professional Intuition: A PIC change instantly initiates a 7-day Board
notification clock and mandates a day-one controlled substance inventory.
